Literature DB >> 2538556

Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

R Rupprecht1, K P Lesch.   

Abstract

Psychoneuroendocrinology is of major importance in the biological research of depression. Most studies have focussed on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis but other endocrine systems such as the hypothalamic-pituitary-thyroid (HPT), hypothalamic-pituitary-somatotropic (HPS), and the hypothalamic-pituitary-gonadal (HPG) axis have also been shown to be involved in the psychobiology of depression. There are close interrelations between various endocrine axes which possibly are affected during depressive illness. A variety of neuroendocrine abnormalities has been detected in depressive disorder but the pathophysiology of these derangements remains still unclear. Although the currently used neuroendocrine tests are not of diagnostic validity they may help to clarify the pathophysiological significance of the complex regulatory mechanisms of different neuroendocrine axes in affective disorders. Neuroendocrine regulation is determined both by peripheral and central mechanisms which both have to be adequately considered as well as potent interactions between various endocrine systems in further neuroendocrine depression research.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538556     DOI: 10.1007/bf01258628

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  94 in total

1.  Function of the adrenal cortex in patients with major depression.

Authors:  N H Kalin; G Dawson; P Tariot; S Shelton; C Barksdale; S Weiler; M Thienemann
Journal:  Psychiatry Res       Date:  1987-10       Impact factor: 3.222

2.  Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls.

Authors:  R Rupprecht; C Rupprecht; M Rupprecht; M Noder; J Mahlstedt
Journal:  Biol Psychiatry       Date:  1989-01       Impact factor: 13.382

3.  Shortened dexamethasone half-life in depressed dexamethasone nonsuppressors.

Authors:  F Holsboer; K Wiedemann; E Boll
Journal:  Arch Gen Psychiatry       Date:  1986-08

4.  ACTH and the dexamethasone suppression test in depression.

Authors:  S J Nasr; C Rodgers; G Pandey; E G Altman; F M Gaviria; J M Davis
Journal:  Biol Psychiatry       Date:  1983-09       Impact factor: 13.382

Review 5.  The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review.

Authors:  G W Arana; R J Baldessarini; M Ornsteen
Journal:  Arch Gen Psychiatry       Date:  1985-12

6.  TSH and LH responses in subtypes of depression.

Authors:  P G Ettigi; G M Brown; J A Seggie
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

7.  Dexamethasone suppresses beta-endorphin in humans.

Authors:  D E Krantz; W A Brown
Journal:  Psychoneuroendocrinology       Date:  1985       Impact factor: 4.905

8.  Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers.

Authors:  D Naber; D Pickar; R M Post; D P Van Kammen; R N Waters; J C Ballenger; F K Goodwin; W E Bunney
Journal:  Am J Psychiatry       Date:  1981-11       Impact factor: 18.112

9.  Dexamethasone suppression of 11-deoxycorticosterone, corticosterone and cortisol in depressed female patients and normal controls.

Authors:  F Holsboer; H G Doerr; W G Sippell
Journal:  Acta Psychiatr Scand       Date:  1982-07       Impact factor: 6.392

10.  Neuroendocrine regulation in depressed postmenopausal women and healthy subjects.

Authors:  J D Amsterdam; A Winokur; I Lucki; P Snyder
Journal:  Acta Psychiatr Scand       Date:  1983-01       Impact factor: 6.392

View more
  6 in total

Review 1.  Endocrine disturbances in depression.

Authors:  M A Tichomirowa; M E Keck; H J Schneider; M Paez-Pereda; U Renner; F Holsboer; G K Stalla
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 2.  The neuroendocrine approach to psychiatric disorders: a critical appraisal.

Authors:  E E Müller
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.

Authors:  J Fritze; M Lanczik; E Sofic; M Struck; P Riederer
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

Review 4.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

5.  The low dose dexamethasone suppression test: effect of time of administration and dose.

Authors:  C Barton; S March; G A Wittert
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

Review 6.  Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction.

Authors:  K P Lesch; R Rupprecht
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.